JP2025165933A5 - - Google Patents
Info
- Publication number
- JP2025165933A5 JP2025165933A5 JP2025114666A JP2025114666A JP2025165933A5 JP 2025165933 A5 JP2025165933 A5 JP 2025165933A5 JP 2025114666 A JP2025114666 A JP 2025114666A JP 2025114666 A JP2025114666 A JP 2025114666A JP 2025165933 A5 JP2025165933 A5 JP 2025165933A5
- Authority
- JP
- Japan
- Prior art keywords
- dihydrate
- salt
- salcardin
- diffraction pattern
- ray powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962798467P | 2019-01-29 | 2019-01-29 | |
| US62/798,467 | 2019-01-29 | ||
| US202062959687P | 2020-01-10 | 2020-01-10 | |
| US62/959,687 | 2020-01-10 | ||
| PCT/US2020/015370 WO2020159959A1 (en) | 2019-01-29 | 2020-01-28 | Sulcardine salts |
| JP2021542541A JP2022518906A (ja) | 2019-01-29 | 2020-01-28 | サルカルディン塩 |
| JP2023188791A JP2024039020A (ja) | 2019-01-29 | 2023-11-02 | サルカルディン塩 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023188791A Division JP2024039020A (ja) | 2019-01-29 | 2023-11-02 | サルカルディン塩 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025165933A JP2025165933A (ja) | 2025-11-05 |
| JP2025165933A5 true JP2025165933A5 (https=) | 2026-01-06 |
Family
ID=69724142
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021542541A Pending JP2022518906A (ja) | 2019-01-29 | 2020-01-28 | サルカルディン塩 |
| JP2023188791A Pending JP2024039020A (ja) | 2019-01-29 | 2023-11-02 | サルカルディン塩 |
| JP2025114666A Pending JP2025165933A (ja) | 2019-01-29 | 2025-07-07 | サルカルディン塩 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021542541A Pending JP2022518906A (ja) | 2019-01-29 | 2020-01-28 | サルカルディン塩 |
| JP2023188791A Pending JP2024039020A (ja) | 2019-01-29 | 2023-11-02 | サルカルディン塩 |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US11426382B2 (https=) |
| EP (1) | EP3917921A1 (https=) |
| JP (3) | JP2022518906A (https=) |
| KR (2) | KR102405199B1 (https=) |
| CN (2) | CN112638903B (https=) |
| AU (1) | AU2020216925B2 (https=) |
| BR (1) | BR112021014640A8 (https=) |
| CA (1) | CA3128152A1 (https=) |
| CL (1) | CL2021001968A1 (https=) |
| CO (1) | CO2021011042A2 (https=) |
| IL (1) | IL285184B2 (https=) |
| MX (2) | MX2021009033A (https=) |
| PH (1) | PH12021551818A1 (https=) |
| SG (1) | SG11202108160YA (https=) |
| WO (1) | WO2020159959A1 (https=) |
| ZA (2) | ZA202105344B (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113453677A (zh) | 2018-12-13 | 2021-09-28 | 沪亚生物国际有限责任公司 | 用于治疗急性心房颤动的舒卡定施用 |
| SG11202108160YA (en) | 2019-01-29 | 2021-08-30 | Huya Bioscience International Llc | Sulcardine salts |
| IL298907A (en) * | 2020-06-12 | 2023-02-01 | Huyabio Int Llc | Administering sulcardin for the treatment of acute atrial fibrillation |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1172908C (zh) | 1999-12-10 | 2004-10-27 | 中国科学院上海药物研究所 | N-取代苄基或苯基芳香磺酰胺化合物及其用途 |
| CN1299813C (zh) | 2004-12-28 | 2007-02-14 | 华南理工大学 | 自动撕膜落料及多样性搅拌的机构和控制装置 |
| CN1939298A (zh) * | 2005-09-29 | 2007-04-04 | 中国科学院上海药物研究所 | 硫酸舒欣啶固体和靶向制剂及其制备方法 |
| EP2501381B1 (en) * | 2009-11-17 | 2017-07-26 | Huya Bioscience International LLC | Treatment of atrial fibrillation |
| EP2501380B1 (en) | 2009-11-17 | 2016-01-27 | Huya Bioscience International LLC | Slow infusion of sulcardine and its salts |
| MA41599A (fr) * | 2015-02-26 | 2018-01-02 | Array Biopharma Inc | Formes cristallines d'un composé pyrrolopyridine |
| AU2016272089B2 (en) | 2015-06-03 | 2021-02-18 | Triastek, Inc. | Dosage forms and use thereof |
| AU2017261372B2 (en) | 2016-05-05 | 2019-02-14 | Triastek, Inc. | Controlled release dosage form |
| EP3573602A4 (en) | 2017-01-26 | 2020-09-16 | Triastek, Inc. | DOSAGE FORMS OF CONTROLLED RELEASE AT SPECIFIC GASTROINTESTINAL SITES |
| AU2018224136B2 (en) * | 2017-02-24 | 2021-10-21 | Gilead Sciences, Inc. | Inhibitors of Bruton's Tyrosine Kinase |
| CN113453677A (zh) | 2018-12-13 | 2021-09-28 | 沪亚生物国际有限责任公司 | 用于治疗急性心房颤动的舒卡定施用 |
| SG11202108160YA (en) * | 2019-01-29 | 2021-08-30 | Huya Bioscience International Llc | Sulcardine salts |
-
2020
- 2020-01-28 SG SG11202108160YA patent/SG11202108160YA/en unknown
- 2020-01-28 MX MX2021009033A patent/MX2021009033A/es unknown
- 2020-01-28 JP JP2021542541A patent/JP2022518906A/ja active Pending
- 2020-01-28 BR BR112021014640A patent/BR112021014640A8/pt unknown
- 2020-01-28 KR KR1020217027357A patent/KR102405199B1/ko active Active
- 2020-01-28 WO PCT/US2020/015370 patent/WO2020159959A1/en not_active Ceased
- 2020-01-28 AU AU2020216925A patent/AU2020216925B2/en active Active
- 2020-01-28 CA CA3128152A patent/CA3128152A1/en active Pending
- 2020-01-28 EP EP20707973.2A patent/EP3917921A1/en active Pending
- 2020-01-28 CN CN202080004796.1A patent/CN112638903B/zh active Active
- 2020-01-28 CN CN202211089980.8A patent/CN115385871A/zh active Pending
- 2020-01-28 IL IL285184A patent/IL285184B2/en unknown
- 2020-01-28 PH PH1/2021/551818A patent/PH12021551818A1/en unknown
- 2020-01-28 KR KR1020227017874A patent/KR102697726B1/ko active Active
- 2020-01-28 US US16/775,142 patent/US11426382B2/en active Active
- 2020-10-23 US US17/079,347 patent/US11020374B2/en active Active
-
2021
- 2021-07-27 MX MX2023014776A patent/MX2023014776A/es unknown
- 2021-07-27 CL CL2021001968A patent/CL2021001968A1/es unknown
- 2021-07-28 ZA ZA2021/05344A patent/ZA202105344B/en unknown
- 2021-08-23 CO CONC2021/0011042A patent/CO2021011042A2/es unknown
- 2021-10-05 ZA ZA2021/07474A patent/ZA202107474B/en unknown
-
2022
- 2022-07-11 US US17/862,117 patent/US20250144072A9/en active Pending
-
2023
- 2023-11-02 JP JP2023188791A patent/JP2024039020A/ja active Pending
-
2025
- 2025-07-07 JP JP2025114666A patent/JP2025165933A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025165933A5 (https=) | ||
| JP2023522250A5 (https=) | ||
| JP2022121594A5 (https=) | ||
| JP2021536511A5 (https=) | ||
| JP2020511467A5 (https=) | ||
| JP2022532790A5 (https=) | ||
| JP2014527042A5 (https=) | ||
| IL214086A (en) | Malt salt of n- {4 - {[7,6- bis (methyllaxy) quinoline-4-yl] oxy} phenyl) - n- (4-fluorophenyl) cyclopropane-1,1-dicarboxamide, and crystalline forms for cancer treatment | |
| JP2023002516A5 (https=) | ||
| JP2022518906A5 (https=) | ||
| JP2022502500A5 (https=) | ||
| JP2022543655A5 (https=) | ||
| JP2023553930A5 (https=) | ||
| JP2023109937A5 (https=) | ||
| JP2023027066A5 (https=) | ||
| PE20081157A1 (es) | Forma cristalina de hemifumarato de alisquireno | |
| JP2015522037A5 (https=) | ||
| JP2005507892A5 (https=) | ||
| JP2021530554A5 (https=) | ||
| JP2020528913A5 (https=) | ||
| RU2020111019A (ru) | Полиморфная форма tg02 | |
| JP2023500060A5 (https=) | ||
| HUP9701778A2 (hu) | Raloxifen alkalmazása mellrák megelőzésére alkalmas gyógyszerkészítmény előállítására | |
| JP2022544559A5 (https=) | ||
| CA2437994A1 (en) | Crystalline forms of pyrimidine nucleoside derivative |